Start for free
Start for free
Dementia Discovery Fund logo

Dementia Discovery Fund

Europe, England, United Kingdom, London

Description

The largest family of specialized venture capital funds that invests exclusively in companies developing novel therapeutics for dementia

Investor Profile

Dementia Discovery Fund has made 43 investments, with 5 in the past 12 months and 44% as lead.

Stage Focus

  • Seed (40%)
  • Series A (28%)
  • Series Unknown (16%)
  • Series B (12%)
  • Series D (2%)
  • Series E (2%)

Country Focus

  • United States (60%)
  • United Kingdom (37%)
  • Israel (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Medical
  • Pharmaceutical
  • Genetics
  • Biopharma
  • Precision Medicine
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dementia Discovery Fund frequently co-invest with?

Amgen Ventures
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 6
SV Health Investors
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 8
Dolby Family Ventures
Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 10
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 5
Mission Bay Capital
Mission Bay Capital
North America, California, United States, San Francisco
Co-Investments: 5
MRL Ventures Fund
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
MP Healthcare Venture Management
MP Healthcare Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 6
Polaris Partners
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 4
AbbVie Biotech Ventures
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 7
Takeda Ventures
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 5

Which angels does Dementia Discovery Fund often collaborate with?

BG
Bill Gates
North America, Washington, United States, Seattle
Shared Deals: 1

What are some of recent deals done by Dementia Discovery Fund?

Montara Therapeutics

San Francisco, California, United States

Montara Therapeutics is a biotechnology company.

BiopharmaBiotechnologyMedicalWellness
SeedMar 13, 2025
Amount Raised: $20,000,000
TRIMTECH Therapeutics

Cambridge, Massachusetts, United States

TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.

BiotechnologyMedicalTherapeutics
SeedMar 5, 2025
Amount Raised: $31,000,000
Harness Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Harness Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.

BiotechnologyLife Science
Series UnknownJan 27, 2025
LOQUS23 THERAPEUTICS

London, England, United Kingdom

LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease.

Biotechnology
Series AOct 2, 2024
Amount Raised: $46,420,022
Montara Therapeutics

San Francisco, California, United States

Montara Therapeutics is a biotechnology company.

BiopharmaBiotechnologyMedicalWellness
SeedJul 30, 2024
Amount Raised: $8,000,000
Sudo Biosciences

Carmel, Indiana, United States

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

BiopharmaBiotechnologyHealth CareLife ScienceMedical
Series BFeb 13, 2024
Amount Raised: $30,000,000
AstronauTx

Reading, Reading, United Kingdom

AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes.

BiotechnologyPharmaceutical
Series AOct 8, 2023
Amount Raised: $58,653,248
Violet Therapeutics

Cambridge, Massachusetts, United States

Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome.

Health CareMedicalTherapeutics
SeedMay 5, 2023
Amount Raised: $10,600,000
Therini Bio

San Francisco, California, United States

Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series AApr 27, 2023
Amount Raised: $36,000,000
QurAlis

Cambridge, Massachusetts, United States

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

BiotechnologyGeneticsHealth CarePrecision MedicineTherapeutics
Series BMar 9, 2023
Amount Raised: $88,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator